Home
About
Meetings
News
Research
PulmonaryOedema
MI-AVR
Endoscopic Mitral Surgeons
Mini Mitral Trial
Tricuspid Valve
Presentation Award
Contact
News
What's Happening
NOV
08
Microbiome therapy shows promise for preventing deadly bloodstream infections in early trial
By:
on
NOV
08
Researchers at City of Hope and collaborators have pioneered a new approach to preventing dangerous bloodstream infections in patients receiving donor stem cell transplants for blood cancers. The first-of-its-kind therapy delivers 16 carefully selected beneficial bacteria designed to restore the microbiome and fight harmful pathogens.
Read more >>
NOV
08
Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials
By:
on
NOV
08
For people with painful knee osteoarthritis (OA) who are overweight or have obesity, everyday activities such as walking, climbing stairs and standing up from a chair can be difficult. In two Northwestern University–led Phase III clinical trials involving more than 1,000 participants combined, those taking the highest dose of retatrutide, a new experimental weight-loss injectable drug, lost about one-quarter of their body weight on average.
Read more >>
NOV
08
Single iron infusion improved exercise capacity in people with the most common form of heart failure
By:
on
NOV
08
A new study by investigators from the Mass General Brigham Heart and Vascular Institute found that a single iron infusion improved exercise capacity in people with heart failure with preserved ejection fraction (HFpEF) and iron deficiency. The findings suggest that replenishing iron could help address the physical limitations associated with this condition. Results were presented at the 2026 American Heart Association Scientific Sessions and published simultaneously in Circulation.
Read more >>
NOV
07
Financial incentives nearly double quit rates among underserved people who smoke in national study
By:
on
NOV
07
Offering financial incentives to people trying to quit smoking nearly doubled cessation rates among medically underserved adults undergoing lung cancer screening, according to a large national clinical trial involving Henry Ford Health.
Read more >>
NOV
07
Potential driver of severe early-onset preeclampsia identified
By:
on
NOV
07
Severe early-onset preeclampsia has confounded doctors for more than 2,000 years. It can strike as early as 20 weeks into pregnancy, sending blood pressure soaring and putting both the mother and baby at risk.
Read more >>
NOV
07
Normal-looking sleep can mask memory problems, study suggests
By:
on
NOV
07
A new mouse study that set out to test how sleep helps stabilize new memories has identified cells that may offer a genetic target for accessing circuits implicated in cognitive disorders. Researchers led by Min Xu and Wanling Peng from the Institute of Neuroscience at the Chinese Academy of Sciences focused on interneurons that gate the generation of ripples, which are brief bursts of electrical activity that are critical for memory consolidation.
Read more >>
NOV
07
New treatment may cure common hormonal cause of high blood pressure
By:
on
NOV
07
A study led by Queen Mary University of London has found that a new treatment could offer a lasting cure for some people with a common hormonal cause of high blood pressure, even after they stop taking medication.
Read more >>
NOV
07
Heart researchers unpack neutral findings from ZEUS, an anti-inflammatory clinical trial
By:
on
NOV
07
Like cholesterol, inflammation causally contributes to the risk of cardiovascular disease, but findings from the clinical trial ZEUS indicate that the road to targeting inflammation may be less straightforward than once thought. ZEUS, a global phase 3 clinical trial led by Mass General Brigham researcher Paul Ridker, M.D., tested a drug that targets interleukin-6 (IL-6), a downstream inflammatory molecule. IL-6 inhibitors are commonly used to treat autoimmune disorders. However, while the new drug known as ziltivekimab lowered IL-6 levels, it did not reduce cardiovascular event rates compared to placebo.
Read more >>
NOV
07
Study: Higher rates of parkinsonism among older adults with autism
By:
on
NOV
07
Middle-aged and older adults with autism are more likely to have co-occurring parkinsonism than adults without autism or intellectual disability, according to a new study led by George Washington University researchers in the Department of Speech, Language and Hearing Sciences.
Read more >>
NOV
07
New study identifies biological mechanism driving therapy resistance in advanced prostate cancer
By:
on
NOV
07
A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer Center has identified a previously unknown biological mechanism that controls cell identity and treatment resistance in advanced prostate cancer.
Read more >>
More Posts
BISMICS is a registered charity in England and Wales No.
1172855
Address: 5 Richmond Road, East Finchley,
London N2 8JT
Share by: